# The FGF/FGFR Signalling Pathway:

> **NCT03303885** · — · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Nice** · enrollment: 421 (actual)

## Conditions studied

- Liposarcoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03303885
- **Lead sponsor:** Centre Hospitalier Universitaire de Nice
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-01
- **Primary completion:** 2019-03-29
- **Final completion:** 2019-03-29
- **Target enrollment:** 421 (ACTUAL)
- **Last updated:** 2020-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03303885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03303885, "The FGF/FGFR Signalling Pathway:". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03303885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*